Background: The study of age-associated changes in the bone marrow (BM), a key organ for hematopoiesis and immune regulation, is crucial to understanding inflammatory processes linked to cardiovascular diseases. Notably, aging is associated with impaired mobilization of BM-derived cardioprotective CD34+ hematopoietic stem/progenitor cells (HSPCs), resulting in a lower frequency in the circulation and poorer cardiovascular outcomes. HSPCs pharmacological mobilizers (G-CSF, AMD3100) and sympathetic signaling stimulator (norepinephrine, NE) function mainly by acting on CD146+ Bone marrow stromal cells (BMSCs), key cellular players in this process. In this study, we developed a human in vitro BM simplified experimental model to assess the impact of aging on CD146+ BMSCs in this context. Methods: CD146+ BMSCs were isolated from 29 human subjects, stratified into middle-aged (middle-aged, ≤66 years; N = 13) and older adults (older adult, ≥75 years; N = 16). For functional assays, bone marrow HSPCs from a single donor (female, 64 years) were used. The in vitro BM simplified experimental model was developed by co-culturing CD146+ BMSC and CD34+ HSPCs in a transwell system. After treatment with mobilizing agents, CD146+ BMSCs’ viability, HSPC migration, transcriptome, metabolism, and paracrine activity were assessed. Results: AMD3100 enhanced HSPC migration in the model using MA-derived CD146+ BMSCs but not in OA-derived cells. RNA sequencing identified 9 ageassociated genes, with validated downregulation of NRK and upregulation of PDK4, AQP1, and LMO2 in OA CD146+ BMSC. Moreover, a differential gene expression response to mobilizing treatments was observed between groups. Cell-conditioned media from OA CD146+ BMSCs showed stronger chemoattractant effects on peripheral blood mononuclear cells and presented increased VCAM-1 levels. No age-related effects on oxidative respiration were observed. Conclusion: In this study, a BM in vitro co-culture system was developed to study CD146+ BMSC-dependent CD34+ mobilization in a subject-specific manner, and the complexity of the impact of aging on CD146+ BMSC and their response to mobilizing agents was highlighted.

Impact of aging on CD146+ mesenchymal stromal cells-mediated regulation of bone marrow CD34+ hematopoietic stem/progenitor cell mobilization / M. Campanile, M.L.N.. - In: FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY. - ISSN 2296-4185. - 14:(2026 May 07), pp. 1802093.1-1802093.18. [10.3389/fbioe.2026.1802093]

Impact of aging on CD146+ mesenchymal stromal cells-mediated regulation of bone marrow CD34+ hematopoietic stem/progenitor cell mobilization

M. Campanile
Primo
;
A. Fantin;
2026

Abstract

Background: The study of age-associated changes in the bone marrow (BM), a key organ for hematopoiesis and immune regulation, is crucial to understanding inflammatory processes linked to cardiovascular diseases. Notably, aging is associated with impaired mobilization of BM-derived cardioprotective CD34+ hematopoietic stem/progenitor cells (HSPCs), resulting in a lower frequency in the circulation and poorer cardiovascular outcomes. HSPCs pharmacological mobilizers (G-CSF, AMD3100) and sympathetic signaling stimulator (norepinephrine, NE) function mainly by acting on CD146+ Bone marrow stromal cells (BMSCs), key cellular players in this process. In this study, we developed a human in vitro BM simplified experimental model to assess the impact of aging on CD146+ BMSCs in this context. Methods: CD146+ BMSCs were isolated from 29 human subjects, stratified into middle-aged (middle-aged, ≤66 years; N = 13) and older adults (older adult, ≥75 years; N = 16). For functional assays, bone marrow HSPCs from a single donor (female, 64 years) were used. The in vitro BM simplified experimental model was developed by co-culturing CD146+ BMSC and CD34+ HSPCs in a transwell system. After treatment with mobilizing agents, CD146+ BMSCs’ viability, HSPC migration, transcriptome, metabolism, and paracrine activity were assessed. Results: AMD3100 enhanced HSPC migration in the model using MA-derived CD146+ BMSCs but not in OA-derived cells. RNA sequencing identified 9 ageassociated genes, with validated downregulation of NRK and upregulation of PDK4, AQP1, and LMO2 in OA CD146+ BMSC. Moreover, a differential gene expression response to mobilizing treatments was observed between groups. Cell-conditioned media from OA CD146+ BMSCs showed stronger chemoattractant effects on peripheral blood mononuclear cells and presented increased VCAM-1 levels. No age-related effects on oxidative respiration were observed. Conclusion: In this study, a BM in vitro co-culture system was developed to study CD146+ BMSC-dependent CD34+ mobilization in a subject-specific manner, and the complexity of the impact of aging on CD146+ BMSC and their response to mobilizing agents was highlighted.
aging; bone marrow; hematopoietic stem/progenitor cells; In vitro models; migration; stromal cells; vasculature
Settore BIOS-08/A - Biologia molecolare
Settore BIOS-10/A - Biologia cellulare e applicata
Settore BIOS-06/A - Fisiologia
7-mag-2026
https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2026.1802093/full
Article (author)
File in questo prodotto:
File Dimensione Formato  
PUBLISHED_PAPER_fbioe-14-1802093.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Licenza: Creative commons
Dimensione 3.59 MB
Formato Adobe PDF
3.59 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1255155
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex ND
social impact